Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

90 trials

NCT06239194
Recruiting
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 · United States · 6 sites
Registry update: 15 Oct 2026
NCT06726564
Recruiting
A Study of MT027 in Patients with Pleural Malignant Tumors
Phase 1 · China · 1 site
Registry update: 10 Dec 2024
NCT06196294
Recruiting
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
Phase 1 · China · 1 site
Registry update: 26 Jun 2024
NCT06051695
Recruiting
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Phase 1/2 · United States · 12 sites
Registry update: 12 Jun 2026
NCT05655078
Recruiting
Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma
Not applicable · United Kingdom · 25 sites
Registry update: 30 Mar 2026
NCT06637345
Recruiting
Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO)
Not applicable · Italy · 1 site
Registry update: 15 Oct 2024
NCT06543069
Recruiting
Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Phase 2 · China · 1 site
Registry update: 7 Aug 2024
NCT05960773
Recruiting
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
Phase 2 · United States · 1 site
Registry update: 16 Oct 2026
NCT06538376
Recruiting
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
Not applicable · United States · 1 site
Registry update: 29 Oct 2025
NCT05628376
Recruiting
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
Not applicable · United Kingdom · 1 site
Registry update: 13 Jul 2026
NCT06057935
Recruiting
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Phase 2 · United States · 13 sites
Registry update: 24 Sept 2026
NCT06037941
Recruiting
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Not applicable · United States · 7 sites
Registry update: 24 Sept 2026
NCT05944237
Recruiting
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2 · United Kingdom · 6 sites
Registry update: 1 Oct 2026
NCT05538806
Recruiting
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Not applicable · Germany, Italy, Netherlands · 23 sites
Registry update: 22 Aug 2025
NCT04969315
Recruiting
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Phase 1/2 · United States · 2 sites
Registry update: 15 Sept 2026
NCT06886672
Recruiting
Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS
Not applicable · Italy · 2 sites
Registry update: 20 Mar 2025
NCT07403630
Recruiting
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Not applicable · Italy · 2 sites
Registry update: 17 Feb 2026
NCT05732831
Recruiting
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/2 · Spain, France, United States · 26 sites
Registry update: 8 Sept 2026
NCT06946498
Recruiting
First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
Not applicable · Greece · 1 site
Registry update: 27 Apr 2025
NCT05730816
Recruiting
MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
Phase 2 · United States · 1 site
Registry update: 21 Nov 2025

Ordered by registry start date. Freshness and sponsorship never change the order.